Search Case Studies

Refine your results

Your selections

21 - 26 results of 26 found.
  • Treating patients with Hodgkin lymphoma when the standard treatment does not work

    UCL research over the last 30 years has developed new treatments for Hodgkin lymphoma and has improved outcomes for patients who do not respond to conventional therapy.

  • Amyloidosis and acute phase proteins: world-leading clinical service

    Research has led to advances in the diagnosis of amyloidosis and clinical characterisation of many new subtypes that has led to new standards of clinical care, improved diagnosis, improved outcomes, and major investment by the NHS.

  • Using evidence of black and minority ethnic underperformance to improve transparency, fairness and standards in medical examinations

    UCL research highlighting medical examination underperformance among UK black and minority ethnic medical students and doctors has informed the development of new or amended guidelines, and changed how international examinations are run.

  • Drug development in an innovative model of collaboration between academia and industry

    Professor Sir Mark Pepys and his team in the UCL Wolfson Drug Discovery Unit have invented new chemical entities for treatment of amyloidosis, Alzheimer’s disease, and other conditions.

  • Acid-sensing ion channels: identifying pain mechanisms leads to development of potential treatments

    As a result of research on acid-sensing ion channels (ASICs) in pain regulation, ASIC-related therapies for a wide variety of conditions are now in clinical trials.

  • Improving treatment of acute leukaemia

    Research conducted at UCL/UCLH over the last 20 years has enabled the identification of adults with acute leukaemia who are most likely to benefit from stem cell transplantation.